JB Chemicals and Pharmaceuticals Ltd recalls Enalapril Maleate Tablets
- Recalling company
- JB Chemicals and Pharmaceuticals Ltd
- Product
- Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.
- Reason
- Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Apr 23, 2026
- Reported
- May 13, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 675 bottles
- Lot / codes
- Lot #: GEH25023, Expires: 6/30/2027
- Company location
- Mumbai
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0520-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0520-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.